Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
275
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study

Linxin Xu1 First Clinical Medical College, Shanxi Medical University, Taiyuan, People’s Republic of China;2 Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, 030001, People’s Republic of ChinaView further author information
,
Junfang Cui3 Department of Geratology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, 030001, People’s Republic of ChinaView further author information
,
Mina Li2 Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, 030001, People’s Republic of ChinaView further author information
,
Qianqian Wu2 Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, 030001, People’s Republic of ChinaView further author information
,
Ming Liu2 Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, 030001, People’s Republic of ChinaView further author information
,
Minggang Xu4 Department of Endocrinology, Changzhi Second People’s Hospital, Changzhi, 046000, People’s Republic of ChinaView further author information
,
Guoliang Shi4 Department of Endocrinology, Changzhi Second People’s Hospital, Changzhi, 046000, People’s Republic of ChinaView further author information
,
Jianhong Yin2 Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, 030001, People’s Republic of ChinaView further author information
&
Jing Yang1 First Clinical Medical College, Shanxi Medical University, Taiyuan, People’s Republic of China;2 Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, 030001, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 1877-1884 | Published online: 18 Jun 2022

References

  • Luís C, Fernandes R, Soares R, von Hafe P. A state of the art review on the novel mediator asprosin in the metabolic syndrome. Porto Biomed J. 2020;5(6):e108. doi:10.1097/j.pbj.0000000000000108
  • Mazur-Bialy AI. Asprosin-A fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature. Nutrients. 2021;13(2):620. doi:10.3390/nu13020620
  • Hoffmann JG, Xie W, Chopra AR. Energy regulation mechanism and therapeutic potential of asprosin. Diabetes. 2020;69(4):559–566. doi:10.2337/dbi19-0009
  • Zhang X, Jiang H, Ma X, Wu H. Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus. J Diabetes Investig. 2020;11(2):349–355. doi:10.1111/jdi.13148
  • Wang R, Lin P, Sun H, Hu W. Increased serum asprosin is correlated with diabetic nephropathy. Diabetol Metab Syndr. 2021;13(1):51. doi:10.1186/s13098-021-00668-x
  • Deng X, Zhao L, Guo C, et al. Higher serum asprosin level is associated with urinary albumin excretion and renal function in type 2 diabetes. Diabetes Metab Syndr Obes. 2020;13:4341–4351. doi:10.2147/DMSO.S283413
  • Zhang H, Hu W, Zhang G. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease. Int Urol Nephrol. 2020;52(8):1517–1522. doi:10.1007/s11255-020-02509-8
  • Goodarzi G, Setayesh L, Fadaei R, et al. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy. Mol Biol Rep. 2021;48(7):5443–5450. doi:10.1007/s11033-021-06551-2
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021 [published correction appears in Diabetes Care. 2021 Sep;44 (9): 2186–2187]. Diabetes Care. 2021;44(Suppl 1):S151–S167. doi:10.2337/dc21-S011
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011 Sep 20;155 (6): 408]. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Miklavcic JJ, Fraser KD, Ploeg J, et al. Effectiveness of a community program for older adults with type 2 diabetes and multimorbidity: a pragmatic randomized controlled trial. BMC Geriatr. 2020;20(1):174. doi:10.1186/s12877-020-01557-0
  • Romere C, Duerrschmid C, Bournat J, et al. Asprosin, a fasting-induced glucogenic protein hormone. Cell. 2016;165(3):566–579. doi:10.1016/j.cell.2016.02.063
  • Duerrschmid C, He Y, Wang C, et al. Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017;23(12):1444–1453. doi:10.1038/nm.4432
  • Wang M, Yin C, Wang L, et al. Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity. Ann Nutr Metab. 2019;75(4):205–212. doi:10.1159/000503808
  • Wen MS, Wang CY, Yeh JK, et al. The role of Asprosin in patients with dilated cardiomyopathy. BMC Cardiovasc Disord. 2020;20(1):402. doi:10.1186/s12872-020-01680-1
  • Brett SE, Ritter JM, Chowienczyk PJ. Diastolic blood pressure changes during exercise positively correlate with serum cholesterol and insulin resistance. Circulation. 2000;101(6):611–615. doi:10.1161/01.cir.101.6.611
  • Schultz MG, Sharman JE. Exercise hypertension. Pulse. 2014;1(3–4):161–176. doi:10.1159/000360975
  • Li X, Liao M, Shen R, et al. Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators Inflamm. 2018;2018:7375294. doi:10.1155/2018/7375294
  • Wei F, Long A, Wang Y. The Asprosin-OLFR734 hormonal signaling axis modulates male fertility. Cell Discov. 2019;5:55. doi:10.1038/s41421-019-0122-x
  • Wiecek M, Szymura J, Maciejczyk M, Kantorowicz M, Szygula Z. Acute anaerobic exercise affects the secretion of asprosin, irisin, and other cytokines - a comparison between sexes. Front Physiol. 2018;9:1782. doi:10.3389/fphys.2018.01782

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.